A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma (Q39860629)
Jump to navigation
Jump to search
scientific article published on 25 June 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma |
scientific article published on 25 June 2010 |
Statements
1 reference
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma (English)
1 reference
Manish A Shah
1 reference
Derek G Power
1 reference
Hedy L Kindler
1 reference
Kyle D Holen
1 reference
Margaret M Kemeny
1 reference
David H Ilson
1 reference
Laura Tang
1 reference
Marinela Capanu
1 reference
John J Wright
1 reference
David P Kelsen
1 reference
25 June 2010
1 reference
1 reference
1475-1481
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference